img

Global Graves Disease Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Graves Disease Treatment Market Insights, Forecast to 2034

Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Global Graves Disease Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Graves Disease Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Graves Disease Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Graves Disease Treatment market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott
Merck & Co
Pfizer, Inc
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Segment by Type
Anti-Thyroid Medication
Radioactive Iodine Therapy

Segment by Application


Hospitals Pharmacies
Retail Pharmacies

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Graves Disease Treatment plant distribution, commercial date of Graves Disease Treatment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Graves Disease Treatment introduction, etc. Graves Disease Treatment Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Graves Disease Treatment
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Graves Disease Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Graves Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anti-Thyroid Medication
1.2.3 Radioactive Iodine Therapy
1.3 Market by Application
1.3.1 Global Graves Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Graves Disease Treatment Sales Estimates and Forecasts 2018-2029
2.2 Global Graves Disease Treatment Revenue by Region
2.2.1 Global Graves Disease Treatment Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Graves Disease Treatment Revenue by Region (2018-2024)
2.2.3 Global Graves Disease Treatment Revenue by Region (2024-2029)
2.2.4 Global Graves Disease Treatment Revenue Market Share by Region (2018-2029)
2.3 Global Graves Disease Treatment Sales Estimates and Forecasts 2018-2029
2.4 Global Graves Disease Treatment Sales by Region
2.4.1 Global Graves Disease Treatment Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Graves Disease Treatment Sales by Region (2018-2024)
2.4.3 Global Graves Disease Treatment Sales by Region (2024-2029)
2.4.4 Global Graves Disease Treatment Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Graves Disease Treatment Sales by Manufacturers
3.1.1 Global Graves Disease Treatment Sales by Manufacturers (2018-2024)
3.1.2 Global Graves Disease Treatment Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Graves Disease Treatment in 2022
3.2 Global Graves Disease Treatment Revenue by Manufacturers
3.2.1 Global Graves Disease Treatment Revenue by Manufacturers (2018-2024)
3.2.2 Global Graves Disease Treatment Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Graves Disease Treatment Revenue in 2022
3.3 Global Key Players of Graves Disease Treatment, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Graves Disease Treatment Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Graves Disease Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Graves Disease Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Graves Disease Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Graves Disease Treatment Sales by Type
4.1.1 Global Graves Disease Treatment Historical Sales by Type (2018-2024)
4.1.2 Global Graves Disease Treatment Forecasted Sales by Type (2024-2029)
4.1.3 Global Graves Disease Treatment Sales Market Share by Type (2018-2029)
4.2 Global Graves Disease Treatment Revenue by Type
4.2.1 Global Graves Disease Treatment Historical Revenue by Type (2018-2024)
4.2.2 Global Graves Disease Treatment Forecasted Revenue by Type (2024-2029)
4.2.3 Global Graves Disease Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Graves Disease Treatment Price by Type
4.3.1 Global Graves Disease Treatment Price by Type (2018-2024)
4.3.2 Global Graves Disease Treatment Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Graves Disease Treatment Sales by Application
5.1.1 Global Graves Disease Treatment Historical Sales by Application (2018-2024)
5.1.2 Global Graves Disease Treatment Forecasted Sales by Application (2024-2029)
5.1.3 Global Graves Disease Treatment Sales Market Share by Application (2018-2029)
5.2 Global Graves Disease Treatment Revenue by Application
5.2.1 Global Graves Disease Treatment Historical Revenue by Application (2018-2024)
5.2.2 Global Graves Disease Treatment Forecasted Revenue by Application (2024-2029)
5.2.3 Global Graves Disease Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Graves Disease Treatment Price by Application
5.3.1 Global Graves Disease Treatment Price by Application (2018-2024)
5.3.2 Global Graves Disease Treatment Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Graves Disease Treatment Market Size by Type
6.1.1 US & Canada Graves Disease Treatment Sales by Type (2018-2029)
6.1.2 US & Canada Graves Disease Treatment Revenue by Type (2018-2029)
6.2 US & Canada Graves Disease Treatment Market Size by Application
6.2.1 US & Canada Graves Disease Treatment Sales by Application (2018-2029)
6.2.2 US & Canada Graves Disease Treatment Revenue by Application (2018-2029)
6.3 US & Canada Graves Disease Treatment Market Size by Country
6.3.1 US & Canada Graves Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Graves Disease Treatment Sales by Country (2018-2029)
6.3.3 US & Canada Graves Disease Treatment Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Graves Disease Treatment Market Size by Type
7.1.1 Europe Graves Disease Treatment Sales by Type (2018-2029)
7.1.2 Europe Graves Disease Treatment Revenue by Type (2018-2029)
7.2 Europe Graves Disease Treatment Market Size by Application
7.2.1 Europe Graves Disease Treatment Sales by Application (2018-2029)
7.2.2 Europe Graves Disease Treatment Revenue by Application (2018-2029)
7.3 Europe Graves Disease Treatment Market Size by Country
7.3.1 Europe Graves Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Graves Disease Treatment Sales by Country (2018-2029)
7.3.3 Europe Graves Disease Treatment Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Graves Disease Treatment Market Size
8.1.1 China Graves Disease Treatment Sales (2018-2029)
8.1.2 China Graves Disease Treatment Revenue (2018-2029)
8.2 China Graves Disease Treatment Market Size by Application
8.2.1 China Graves Disease Treatment Sales by Application (2018-2029)
8.2.2 China Graves Disease Treatment Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Graves Disease Treatment Market Size by Type
9.1.1 Asia Graves Disease Treatment Sales by Type (2018-2029)
9.1.2 Asia Graves Disease Treatment Revenue by Type (2018-2029)
9.2 Asia Graves Disease Treatment Market Size by Application
9.2.1 Asia Graves Disease Treatment Sales by Application (2018-2029)
9.2.2 Asia Graves Disease Treatment Revenue by Application (2018-2029)
9.3 Asia Graves Disease Treatment Sales by Region
9.3.1 Asia Graves Disease Treatment Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Graves Disease Treatment Revenue by Region (2018-2029)
9.3.3 Asia Graves Disease Treatment Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Graves Disease Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Graves Disease Treatment Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Graves Disease Treatment Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Graves Disease Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Graves Disease Treatment Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Graves Disease Treatment Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Graves Disease Treatment Sales by Country
10.3.1 Middle East, Africa and Latin America Graves Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Graves Disease Treatment Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Graves Disease Treatment Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Abbott Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Overview
11.2.3 Merck & Co Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck & Co Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Recent Developments
11.3 Pfizer, Inc
11.3.1 Pfizer, Inc Company Information
11.3.2 Pfizer, Inc Overview
11.3.3 Pfizer, Inc Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer, Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer, Inc Recent Developments
11.4 AbbVie, Inc
11.4.1 AbbVie, Inc Company Information
11.4.2 AbbVie, Inc Overview
11.4.3 AbbVie, Inc Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AbbVie, Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AbbVie, Inc Recent Developments
11.5 Mylan N.V
11.5.1 Mylan N.V Company Information
11.5.2 Mylan N.V Overview
11.5.3 Mylan N.V Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan N.V Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan N.V Recent Developments
11.6 Allergan, plc
11.6.1 Allergan, plc Company Information
11.6.2 Allergan, plc Overview
11.6.3 Allergan, plc Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Allergan, plc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allergan, plc Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Overview
11.7.3 Novartis AG Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novartis AG Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG Recent Developments
11.8 Apitope
11.8.1 Apitope Company Information
11.8.2 Apitope Overview
11.8.3 Apitope Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Apitope Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apitope Recent Developments
11.9 Amgen INC.
11.9.1 Amgen INC. Company Information
11.9.2 Amgen INC. Overview
11.9.3 Amgen INC. Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Amgen INC. Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amgen INC. Recent Developments
11.10 Sun Pharmaceuticals Industries LTD
11.10.1 Sun Pharmaceuticals Industries LTD Company Information
11.10.2 Sun Pharmaceuticals Industries LTD Overview
11.10.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sun Pharmaceuticals Industries LTD Recent Developments
11.11 Immunovant Inc
11.11.1 Immunovant Inc Company Information
11.11.2 Immunovant Inc Overview
11.11.3 Immunovant Inc Graves Disease Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Immunovant Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Immunovant Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Graves Disease Treatment Industry Chain Analysis
12.2 Graves Disease Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Graves Disease Treatment Production Mode & Process
12.4 Graves Disease Treatment Sales and Marketing
12.4.1 Graves Disease Treatment Sales Channels
12.4.2 Graves Disease Treatment Distributors
12.5 Graves Disease Treatment Customers
13 Market Dynamics
13.1 Graves Disease Treatment Industry Trends
13.2 Graves Disease Treatment Market Drivers
13.3 Graves Disease Treatment Market Challenges
13.4 Graves Disease Treatment Market Restraints
14 Key Findings in The Global Graves Disease Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Graves Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Anti-Thyroid Medication
Table 3. Major Manufacturers of Radioactive Iodine Therapy
Table 4. Global Graves Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Graves Disease Treatment Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Graves Disease Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Graves Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Graves Disease Treatment Revenue Market Share by Region (2018-2024)
Table 9. Global Graves Disease Treatment Revenue Market Share by Region (2024-2029)
Table 10. Global Graves Disease Treatment Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Graves Disease Treatment Sales by Region (2018-2024) & (K Units)
Table 12. Global Graves Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 13. Global Graves Disease Treatment Sales Market Share by Region (2018-2024)
Table 14. Global Graves Disease Treatment Sales Market Share by Region (2024-2029)
Table 15. Global Graves Disease Treatment Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Graves Disease Treatment Sales Share by Manufacturers (2018-2024)
Table 17. Global Graves Disease Treatment Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Graves Disease Treatment Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Graves Disease Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Graves Disease Treatment Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Graves Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Graves Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease Treatment as of 2022)
Table 23. Global Key Manufacturers of Graves Disease Treatment, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Graves Disease Treatment, Product Offered and Application
Table 25. Global Key Manufacturers of Graves Disease Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 28. Global Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 29. Global Graves Disease Treatment Sales Share by Type (2018-2024)
Table 30. Global Graves Disease Treatment Sales Share by Type (2024-2029)
Table 31. Global Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Graves Disease Treatment Revenue Share by Type (2018-2024)
Table 34. Global Graves Disease Treatment Revenue Share by Type (2024-2029)
Table 35. Graves Disease Treatment Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Graves Disease Treatment Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 38. Global Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 39. Global Graves Disease Treatment Sales Share by Application (2018-2024)
Table 40. Global Graves Disease Treatment Sales Share by Application (2024-2029)
Table 41. Global Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Graves Disease Treatment Revenue Share by Application (2018-2024)
Table 44. Global Graves Disease Treatment Revenue Share by Application (2024-2029)
Table 45. Graves Disease Treatment Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Graves Disease Treatment Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Graves Disease Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Graves Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Graves Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Graves Disease Treatment Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Graves Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 60. Europe Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 61. Europe Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 62. Europe Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 65. Europe Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 66. Europe Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Graves Disease Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Graves Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Graves Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Graves Disease Treatment Sales by Country (2018-2024) & (K Units)
Table 72. Europe Graves Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 73. China Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 74. China Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 75. China Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 78. China Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 79. China Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 82. Asia Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 83. Asia Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 86. Asia Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 87. Asia Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Graves Disease Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Graves Disease Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Graves Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Graves Disease Treatment Sales by Region (2018-2024) & (K Units)
Table 93. Asia Graves Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Graves Disease Treatment Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Graves Disease Treatment Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Graves Disease Treatment Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Graves Disease Treatment Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Graves Disease Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Graves Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Graves Disease Treatment Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Graves Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 107. Abbott Company Information
Table 108. Abbott Description and Major Businesses
Table 109. Abbott Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Abbott Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Abbott Recent Developments
Table 112. Merck & Co Company Information
Table 113. Merck & Co Description and Major Businesses
Table 114. Merck & Co Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck & Co Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck & Co Recent Developments
Table 117. Pfizer, Inc Company Information
Table 118. Pfizer, Inc Description and Major Businesses
Table 119. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer, Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer, Inc Recent Developments
Table 122. AbbVie, Inc Company Information
Table 123. AbbVie, Inc Description and Major Businesses
Table 124. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. AbbVie, Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AbbVie, Inc Recent Developments
Table 127. Mylan N.V Company Information
Table 128. Mylan N.V Description and Major Businesses
Table 129. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Mylan N.V Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Mylan N.V Recent Developments
Table 132. Allergan, plc Company Information
Table 133. Allergan, plc Description and Major Businesses
Table 134. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Allergan, plc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Allergan, plc Recent Developments
Table 137. Novartis AG Company Information
Table 138. Novartis AG Description and Major Businesses
Table 139. Novartis AG Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Novartis AG Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Novartis AG Recent Developments
Table 142. Apitope Company Information
Table 143. Apitope Description and Major Businesses
Table 144. Apitope Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Apitope Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Apitope Recent Developments
Table 147. Amgen INC. Company Information
Table 148. Amgen INC. Description and Major Businesses
Table 149. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Amgen INC. Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Amgen INC. Recent Developments
Table 152. Sun Pharmaceuticals Industries LTD Company Information
Table 153. Sun Pharmaceuticals Industries LTD Description and Major Businesses
Table 154. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sun Pharmaceuticals Industries LTD Recent Developments
Table 157. Immunovant Inc Company Information
Table 158. Immunovant Inc Description and Major Businesses
Table 159. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Immunovant Inc Graves Disease Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Immunovant Inc Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Graves Disease Treatment Distributors List
Table 165. Graves Disease Treatment Customers List
Table 166. Graves Disease Treatment Market Trends
Table 167. Graves Disease Treatment Market Drivers
Table 168. Graves Disease Treatment Market Challenges
Table 169. Graves Disease Treatment Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Graves Disease Treatment Product Picture
Figure 2. Global Graves Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Graves Disease Treatment Market Share by Type in 2022 & 2029
Figure 4. Anti-Thyroid Medication Product Picture
Figure 5. Radioactive Iodine Therapy Product Picture
Figure 6. Global Graves Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Graves Disease Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Graves Disease Treatment Report Years Considered
Figure 11. Global Graves Disease Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Graves Disease Treatment Revenue 2018-2029 (US$ Million)
Figure 13. Global Graves Disease Treatment Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Graves Disease Treatment Revenue Market Share by Region (2018-2029)
Figure 15. Global Graves Disease Treatment Sales 2018-2029 ((K Units)
Figure 16. Global Graves Disease Treatment Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Graves Disease Treatment Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Graves Disease Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Graves Disease Treatment Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Graves Disease Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Graves Disease Treatment Sales YoY (2018-2029) & (K Units)
Figure 22. China Graves Disease Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Graves Disease Treatment Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Graves Disease Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Graves Disease Treatment Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Graves Disease Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Graves Disease Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Graves Disease Treatment in the World: Market Share by Graves Disease Treatment Revenue in 2022
Figure 29. Global Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 31. Global Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 32. Global Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 33. Global Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Graves Disease Treatment Revenue Share by Country (2018-2029)
Figure 39. US & Canada Graves Disease Treatment Sales Share by Country (2018-2029)
Figure 40. U.S. Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 43. Europe Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 44. Europe Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 45. Europe Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 46. Europe Graves Disease Treatment Revenue Share by Country (2018-2029)
Figure 47. Europe Graves Disease Treatment Sales Share by Country (2018-2029)
Figure 48. Germany Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 49. France Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 53. China Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 54. China Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 55. China Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 56. China Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 57. Asia Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 58. Asia Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 59. Asia Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 60. Asia Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 61. Asia Graves Disease Treatment Revenue Share by Region (2018-2029)
Figure 62. Asia Graves Disease Treatment Sales Share by Region (2018-2029)
Figure 63. Japan Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 67. India Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Graves Disease Treatment Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Graves Disease Treatment Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Graves Disease Treatment Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Graves Disease Treatment Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Graves Disease Treatment Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Graves Disease Treatment Sales Share by Country (2018-2029)
Figure 74. Brazil Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Graves Disease Treatment Revenue (2018-2029) & (US$ Million)
Figure 79. Graves Disease Treatment Value Chain
Figure 80. Graves Disease Treatment Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries